Tsumura & Co.
Research Tsumura & Co. (4540.T) on Bullrun: market cap JPY 285.81B, P/E 9.5, dividend yield 4.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4540.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 285.81B
- P/E9.5
- Dividend yield4.1%
- Financial periodFY2026
- RevenueJPY 192.62B
- Revenue growth6.4%
- Net incomeJPY 28.12B
- Free cash flow-JPY 9.66B
- Gross margin47.5%
Valuation Snapshot
latest market cap is JPY 285.81B; P/E is 9.5; dividend yield is 4.1%.
Peer valuation comparison
Latest P/E is 9.52x versus a Healthcare sector median of 21.69x (56.1% below).
Latest dividend yield is 4.14% versus a Healthcare sector median of 2.41% (71.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 192.62B | JPY 28.12B | -JPY 9.66B | 47.5% | 376.28 | JPY 84.08B | JPY 135.16B | JPY 321.73B |
| FY2025 | JPY 181.09B | JPY 32.43B | JPY 4.03B | 50.0% | 427.15 | JPY 73.23B | JPY 70.34B | JPY 300.53B |
| FY2024 | JPY 150.85B | JPY 16.71B | -JPY 14.45B | 45.6% | 219.83 | JPY 78.08B | JPY 79.69B | JPY 270.80B |
| FY2023 | JPY 140.04B | JPY 16.48B | JPY 1.74B | 48.8% | 215.63 | JPY 94.75B | JPY 79.69B | JPY 252.05B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 285.81B | 9.5 | 4.1% | 158 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 158 JPY, yield 4.1%.
| Year | Dividends/share |
|---|---|
| FY2026 | 158 JPY |
| FY2025 | 136 JPY |
| FY2024 | 118 JPY |
| FY2023 | 67 JPY |
| FY2022 | 64 JPY |
About Tsumura & Co.
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tsumura & Co.'s market cap?
Tsumura & Co.'s market capitalization is JPY 285.81B.
What is Tsumura & Co.'s P/E ratio?
Tsumura & Co.'s price-to-earnings (P/E) ratio is 9.5.
Does Tsumura & Co. pay a dividend?
Tsumura & Co. has a dividend yield of 4.1%.
What does Tsumura & Co. do?
Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. In addition, it produces and sells alcoholic beverages and food products.